AI-generated summary
The authors evaluated oral health care quality in 35 patients receiving hematopoietic stem cell transplantation who were given photobiomodulation to prevent and treat oral mucositis, using process and outcome indicators. They report that 66.6% of patients had mucositis during at least one follow-up period, with a predominance of grade I cases. They conclude that the indicators were suitable and that photobiomodulation was effective in improving oral health in the patients studied.
- Participants
- 35
- Who or what was studied
- Patients undergoing hematopoietic stem cell transplantation
- Limits stated in the abstract
- The abstract describes a single group of 35 patients with no control group mentioned, so the effectiveness conclusion cannot be separated from other factors.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Photobiomodulation, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.